Glucagon-like peptide 1 improves insulin resistance in vitro through anti-inflammation of macrophages

Glucagon-like peptide 1 (GLP-1), a kind of gut hormone, is used in the treatment of type 2 diabetes (T2D). Emerging evidence indicates that GLP-1 has anti-inflammatory activity. Chronic inflammation in the adipose tissue of obese individuals is a cause of insulin resistance and T2D. We hypothesized...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, C., Huang, T., Chen, A., Chen, X., Wang, L., Shen, F., Gu, X.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Associação Brasileira de Divulgação Científica 2016
Materias:
Biomedical Sciences
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5188858/
https://www.ncbi.nlm.nih.gov/pubmed/27878229
http://dx.doi.org/10.1590/1414-431X20165826

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5188858/
https://www.ncbi.nlm.nih.gov/pubmed/27878229
http://dx.doi.org/10.1590/1414-431X20165826

Ejemplares similares